• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诊断时患有深度溃疡的儿童克罗恩病患者的长期预后

Long-Term Outcome of Paediatric Crohn's Disease Patients With Deep Ulcerations at Diagnosis.

作者信息

Ronconi Monica S, Neuraz Antoine, Payen Elise, Nader Elie Abi, Lambe Cécile, Campeotto Florence, Talbotec Cécile, Ruemmele Frank M, Pigneur Bénédicte

机构信息

Service de Gastro-Entérologie et Nutrition Pédiatrique, Centre de Référence Des Maladies Rares Digestives (MARDI), Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants Malades, Université Paris Cité, Paris, France.

Department of Biostatistics, Imagine Institute, APHP, Paris, France.

出版信息

Acta Paediatr. 2025 Sep;114(9):2329-2336. doi: 10.1111/apa.70115. Epub 2025 May 7.

DOI:10.1111/apa.70115
PMID:40332985
Abstract

AIM

Presence of deep ulcerations (DU) at diagnosis seems to be predictive of a more severe phenotype in adult Crohn's disease (CD). The aim of our study was to investigate if the presence of DU at diagnosis was associated with a more severe disease course over time in children.

METHODS

In this monocentric retrospective study, we analysed data from paediatric patients with a new diagnosis of CD from 2009 to 2017. Clinical, laboratory data, treatments and complications were recorded for each patient at diagnosis and at 1, 3 and 5 years of follow-up. Patients were compared according to the presence or absence of DU on colonoscopy.

RESULTS

Among the 116 patients included in the study, 52 patients had DU at diagnosis. Comparison showed an increased risk for patients with DU to develop abdominal abscesses (p = 0.045) and to experience more relapses (p = 0.013) at 1 year. At 3 and 5 years, there was no longer any difference between groups. The time from diagnosis to first anti-TNF alpha was shorter in DU patients.

CONCLUSION

The presence of DU at diagnosis is associated with more complications during the first year of follow-up but not after, due to a more active therapeutic management.

摘要

目的

在成人克罗恩病(CD)中,诊断时存在深部溃疡(DU)似乎预示着更严重的表型。我们研究的目的是调查儿童CD患者诊断时存在DU是否与随时间推移更严重的病程相关。

方法

在这项单中心回顾性研究中,我们分析了2009年至2017年新诊断为CD的儿科患者的数据。记录每位患者诊断时以及随访1年、3年和5年时的临床、实验室数据、治疗情况和并发症。根据结肠镜检查时是否存在DU对患者进行比较。

结果

在纳入研究的116例患者中,52例患者诊断时存在DU。比较显示,存在DU的患者在1年时发生腹部脓肿的风险增加(p = 0.045),复发次数更多(p = 0.013)。在3年和5年时,两组之间不再有任何差异。DU患者从诊断到首次使用抗TNF-α的时间较短。

结论

诊断时存在DU与随访第一年期间更多的并发症相关,但在那之后则不然,这是由于更积极的治疗管理。

相似文献

1
Long-Term Outcome of Paediatric Crohn's Disease Patients With Deep Ulcerations at Diagnosis.诊断时患有深度溃疡的儿童克罗恩病患者的长期预后
Acta Paediatr. 2025 Sep;114(9):2329-2336. doi: 10.1111/apa.70115. Epub 2025 May 7.
2
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.干预措施用于克罗恩病和炎症性肠病的腹痛管理。
Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2.
3
Vitamin D for the treatment of inflammatory bowel disease.维生素 D 治疗炎症性肠病。
Cochrane Database Syst Rev. 2023 Oct 2;10(10):CD011806. doi: 10.1002/14651858.CD011806.pub2.
4
Withdrawal of immunosuppressant or biologic therapy for patients with quiescent Crohn's disease.对病情缓解的克罗恩病患者停用免疫抑制剂或生物疗法。
Cochrane Database Syst Rev. 2018 May 12;5(5):CD012540. doi: 10.1002/14651858.CD012540.pub2.
5
Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.硫唑嘌呤和6-巯基嘌呤用于维持克罗恩病手术诱导的缓解状态
Cochrane Database Syst Rev. 2014 Aug 1;2014(8):CD010233. doi: 10.1002/14651858.CD010233.pub2.
6
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
7
Infliximab for maintenance of medically-induced remission in Crohn's disease.英夫利昔单抗维持克罗恩病的药物缓解
Cochrane Database Syst Rev. 2024 Feb 19;2(2):CD012609. doi: 10.1002/14651858.CD012609.pub2.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
Budesonide for maintenance of remission in Crohn's disease.布地奈德用于维持克罗恩病的缓解状态。
Cochrane Database Syst Rev. 2014 Aug 21;2014(8):CD002913. doi: 10.1002/14651858.CD002913.pub3.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.

本文引用的文献

1
Adalimumab Therapy in Pediatric Crohn Disease: A 2-Year Follow-Up Comparing "Top-Down" and "Step-Up" Strategies.阿达木单抗治疗儿童克罗恩病:一项比较“自上而下”和“逐步升级”策略的2年随访研究
J Pediatr Gastroenterol Nutr. 2023 Feb 1;76(2):166-173. doi: 10.1097/MPG.0000000000003643. Epub 2022 Oct 28.
2
New Therapeutic Strategies Have Changed the Natural History of Pediatric Crohn's Disease: A Two-Decade Population-Based Study.新的治疗策略改变了儿童克罗恩病的自然病程:一项为期 20 年的基于人群的研究。
Clin Gastroenterol Hepatol. 2022 Nov;20(11):2588-2597.e1. doi: 10.1016/j.cgh.2022.01.051. Epub 2022 Feb 4.
3
First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: an open-label multicentre randomised controlled trial.
新诊断的中重度克罗恩病儿童一线使用英夫利昔单抗与常规治疗的比较:一项开放标签、多中心随机对照试验。
Gut. 2022 Jan;71(1):34-42. doi: 10.1136/gutjnl-2020-322339. Epub 2020 Dec 31.
4
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.STRIDE-II:炎症性肠病(STRIDE)国际研究组织(IOIBD)治疗靶点选择更新:确定炎症性肠病靶向治疗策略的治疗目标。
Gastroenterology. 2021 Apr;160(5):1570-1583. doi: 10.1053/j.gastro.2020.12.031. Epub 2021 Feb 19.
5
The Medical Management of Paediatric Crohn's Disease: an ECCO-ESPGHAN Guideline Update.儿童克罗恩病的医学管理:欧洲克罗恩病和结肠炎组织(ECCO)-欧洲儿科胃肠病、肝病和营养学会(ESPGHAN)指南更新
J Crohns Colitis. 2020 Oct 7. doi: 10.1093/ecco-jcc/jjaa161.
6
Predicting Outcomes in Pediatric Crohn's Disease for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease-Ahead Program.预测儿童克罗恩病结局以优化管理:来自儿科炎症性肠病前瞻性计划的系统评价和共识声明。
Gastroenterology. 2021 Jan;160(1):403-436.e26. doi: 10.1053/j.gastro.2020.07.065. Epub 2020 Sep 23.
7
Differences in Biologic Utilization and Surgery Rates in Pediatric and Adult Crohn's Disease: Results From a Large Electronic Medical Record-derived Cohort.儿童和成人克罗恩病的生物学利用和手术率差异:来自大型电子病历队列的结果。
Inflamm Bowel Dis. 2021 Jun 15;27(7):1035-1044. doi: 10.1093/ibd/izaa239.
8
Use of Anti-TNF Alpha Blockers Can Reduce Operation Rate and Lead to Growth Gain in Pediatric Crohn's Disease.使用抗肿瘤坏死因子α阻滞剂可降低小儿克罗恩病的手术率并促进生长发育。
Pediatr Gastroenterol Hepatol Nutr. 2019 Jul;22(4):358-368. doi: 10.5223/pghn.2019.22.4.358. Epub 2019 Jun 25.
9
Malignancy and mortality in paediatric-onset inflammatory bowel disease: a 3-year prospective, multinational study from the paediatric IBD Porto group of ESPGHAN.儿科炎症性肠病的恶性肿瘤和死亡率:来自 ESPGHAN 儿科 IBD 波尔图小组的一项为期 3 年的前瞻性、多国研究。
Aliment Pharmacol Ther. 2018 Sep;48(5):523-537. doi: 10.1111/apt.14893. Epub 2018 Jul 8.
10
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial.紧密控制管理对克罗恩病(CALM)的影响:一项多中心、随机、对照的 3 期临床试验。
Lancet. 2017 Dec 23;390(10114):2779-2789. doi: 10.1016/S0140-6736(17)32641-7. Epub 2017 Oct 31.